Iron and protein sufficiency and red cell indices in phenylketonuria

G L Arnold1, R Kirby, C Preston

  • 1Department of Pediatrics, University of Rochester School of Medicine and Dentistry, New York 14642, USA. Georgianne_Arnold@urmc.rochester.edu

Insights

Children with treated phenylketonuria (PKU) may develop anemia due to iron or protein deficiencies. Monitoring ferritin, blood counts, and prealbumin is crucial for early detection and management in all PKU patients.

Area of Science:

  • Biochemistry
  • Pediatric Hematology
  • Nutritional Science

Background:

  • Phenylketonuria (PKU) is a genetic disorder requiring lifelong dietary management.
  • Treated PKU patients may face nutritional challenges impacting hematopoiesis.
  • Understanding hematological profiles in treated PKU is essential for optimal health outcomes.

Purpose of the Study:

  • To evaluate hematopoiesis in children with treated PKU.
  • To assess the impact of iron and protein sufficiency on blood parameters.
  • To identify reliable markers for monitoring nutritional status and hematological health.

Main Methods:

  • Retrospective review of medical records for 41 children with treated PKU.
  • Analysis of hematological parameters including red blood cell indices and iron/protein markers.
  • Correlation of nutritional status (iron, protein) with hematopoiesis.

Main Results:

  • 15% of children with treated PKU presented with anemia.
  • Combined iron and protein depletion was strongly associated with anemia.
  • Iron deficiency without anemia was observed in 10% of patients.
  • Low plasma prealbumin correlated significantly with altered hematopoiesis and poor growth.

Conclusions:

  • Children with treated PKU exhibit altered red blood cell characteristics.
  • Iron and protein depletion can precipitate anemia in this population.
  • Routine monitoring of ferritin, complete blood counts, and prealbumin is recommended for all ages.
Abstract

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Proteins: Dietary Sources and Requirements01:28

Proteins: Dietary Sources and Requirements

Consuming animal-based products offers high-quality proteins that contain optimal levels and combinations of essential amino acids, crucial for tissue repair and growth. Foods like eggs, milk, fish, and most meats are a source of complete proteins. Legumes and cereals are abundant in proteins; however, they typically lack a full range of essential amino acids. As a result, they are considered incomplete protein sources. Some plant sources like soybeans, quinoa, and amaranth do contain complete...
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...